These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17362767)

  • 1. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration.
    Kaudel CP; Frink M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; van Griensven M; Winkler M
    Transplant Proc; 2007 Mar; 39(2):499-502. PubMed ID: 17362767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model.
    Kaudel CP; Frink M; van Griensven M; Schmiddem U; Probst C; Bergmann S; Krettek C; Klempnauer J; Winkler M
    Transplant Proc; 2007 Mar; 39(2):493-8. PubMed ID: 17362766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice.
    Kaudel CP; Schmiddem U; Frink M; Bergmann S; Pape HC; Krettek C; Klempnauer J; Winkler M
    Transplant Proc; 2006 Apr; 38(3):679-81. PubMed ID: 16647442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
    Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury.
    Suleiman M; Cury PM; Pestana JO; Burdmann EA; Bueno V
    Transplant Proc; 2005; 37(1):373-4. PubMed ID: 15808648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs.
    Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M
    J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury.
    da Silva LB; Palma PV; Cury PM; Bueno V
    Int Immunopharmacol; 2007 Dec; 7(13):1609-16. PubMed ID: 17996670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
    Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
    Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 impairs necrosis development after ischemia-reperfusion injury.
    Oliveira CM; Borra RC; Franco M; Schor N; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):854-6. PubMed ID: 15194292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin allograft survival and analysis of renal parameters after FTY720 + tacrolimus treatment in mice.
    Lopes CT; Gallo AP; Palma PV; Cury PM; Bueno V
    Transplant Proc; 2008 Apr; 40(3):856-60. PubMed ID: 18455036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
    Liu L; Wang C; He X; Shang W; Bi Y; Wang D
    Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
    Hofmann M; Brinkmann V; Zerwes HG
    Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 treatment prolongs skin graft survival in a completely incompatible strain combination.
    Lima RS; Nogueira-Martins MF; Silva HT; Pestana JO; Bueno V
    Transplant Proc; 2004 May; 36(4):1015-7. PubMed ID: 15194353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients.
    Sommerer C; Morath C; Giese T; Meuer S; Zeier M
    Transplant Proc; 2008 Jun; 40(5):1416-8. PubMed ID: 18589120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
    Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
    Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.